GeneDx to Participate in Fall Investor Conferences
GeneDx (Nasdaq: WGS), a leader in genomic insights, announced its participation in upcoming investor conferences. The company will attend the UBS Genomic Medicine Summit (August 13-14, 2024), Morgan Stanley Healthcare Conference (September 4-6, 2024), Wells Fargo Healthcare Conference (September 4-6, 2024), and Jefferies London Healthcare Conference (November 19-21, 2024).
GeneDx will participate in a panel discussion on the Future of Genetic Testing at the UBS summit and hold a fireside chat at the Wells Fargo conference. Select presentations will be available via webcast on the company's investor relations website. GeneDx specializes in rare disease diagnostics, offering exome and genome tests to provide personalized healthcare solutions and accelerate drug discovery.
GeneDx (Nasdaq: WGS), un leader nelle intuizioni genomiche, ha annunciato la sua partecipazione a prossimi convegni per investitori. L'azienda parteciperà al UBS Genomic Medicine Summit (13-14 agosto 2024), al Morgan Stanley Healthcare Conference (4-6 settembre 2024), al Wells Fargo Healthcare Conference (4-6 settembre 2024) e al Jefferies London Healthcare Conference (19-21 novembre 2024).
GeneDx prenderà parte a una discussione panel sul Futuro del Test Genetico al summit UBS e organizzerà una conversazione informale al convegno Wells Fargo. Presentazioni selezionate saranno disponibili tramite webcast sul sito web delle relazioni con gli investitori di GeneDx. GeneDx si specializza nella diagnostica delle malattie rare, offrendo test esoma e genoma per fornire soluzioni sanitarie personalizzate e accelerare la scoperta di farmaci.
GeneDx (Nasdaq: WGS), un líder en conocimientos genómicos, anunció su participación en las próximas conferencias para inversionistas. La empresa asistirá al UBS Genomic Medicine Summit (13-14 de agosto de 2024), a la Morgan Stanley Healthcare Conference (4-6 de septiembre de 2024), a la Wells Fargo Healthcare Conference (4-6 de septiembre de 2024) y a la Jefferies London Healthcare Conference (19-21 de noviembre de 2024).
GeneDx participará en una discusión en panel sobre el Futuro de las Pruebas Genéticas en la cumbre de UBS y llevará a cabo una charla informal en la conferencia de Wells Fargo. Presentaciones seleccionadas estarán disponibles a través de webcast en el sitio web de relaciones con inversionistas de GeneDx. GeneDx se especializa en el diagnóstico de enfermedades raras, ofreciendo pruebas de exoma y genoma para proporcionar soluciones de atención personalizada y acelerar el descubrimiento de medicamentos.
GeneDx (Nasdaq: WGS)는 유전체 통찰의 선두주자로서 다가오는 투자자 회의에 참여한다고 발표했습니다. 이 회사는 UBS 유전체 의학 서밋 (2024년 8월 13-14일), 모건 스탠리 헬스케어 회의 (2024년 9월 4-6일), 웰스파고 헬스케어 회의 (2024년 9월 4-6일), 제퍼리스 런던 헬스케어 회의 (2024년 11월 19-21일)에 참석할 예정입니다.
GeneDx는 UBS 서밋에서 유전자 검사 미래에 대한 패널 토론에 참여하고, 웰스파고 회의에서는 소규모 대화를 진행할 것입니다. 선택된 발표는 GeneDx의 투자자 관계 웹사이트를 통해 웹캐스트로 제공될 예정입니다. GeneDx는 희귀 질환 진단을 전문으로 하며, 개인 맞춤형 건강 관리 솔루션을 제공하고 약물 발견을 가속화하기 위해 엑소좀 및 게놈 검사를 제공합니다.
GeneDx (Nasdaq: WGS), un leader dans les informations génomiques, a annoncé sa participation à des conférences pour investisseurs à venir. L'entreprise participera au Sommet de Médecine Génomique UBS (13-14 août 2024), à la Conférence de Santé Morgan Stanley (4-6 septembre 2024), à la Conférence de Santé Wells Fargo (4-6 septembre 2024) et à la Conférence de Santé Jefferies à Londres (19-21 novembre 2024).
GeneDx participera à une discussion en panel sur l'Avenir des Tests Génétiques lors du sommet UBS et animera une discussion informelle à la conférence Wells Fargo. Des présentations sélectionnées seront disponibles par webcast sur le site web des relations avec les investisseurs de GeneDx. GeneDx se spécialise dans le diagnostic des maladies rares, offrant des tests d'exome et de génome pour fournir des solutions de santé personnalisées et accélérer la découverte de médicaments.
GeneDx (Nasdaq: WGS), ein führendes Unternehmen im Bereich genomischer Erkenntnisse, hat seine Teilnahme an bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird am UBS Genomic Medicine Summit (13.-14. August 2024), an der Morgan Stanley Healthcare Conference (4.-6. September 2024), an der Wells Fargo Healthcare Conference (4.-6. September 2024) und an der Jefferies London Healthcare Conference (19.-21. November 2024) teilnehmen.
GeneDx wird an einer Podiumsdiskussion über die Zukunft der genetischen Tests beim UBS-Gipfel teilnehmen und ein informelles Gespräch auf der Wells Fargo-Konferenz führen. Ausgewählte Präsentationen werden über einen Webcast auf der Website für Investor Relations von GeneDx verfügbar sein. GeneDx ist auf die Diagnostik seltener Krankheiten spezialisiert und bietet Exom- und Genomtests an, um personalisierte Gesundheitslösungen bereitzustellen und die Medikamentenentdeckung zu beschleunigen.
- None.
- None.
-
UBS Genomic Medicine Summit – August 13-14, 2024
Dana Point, California
Future of Genetic Testing - Babies and Beyond Panel on Wednesday, August 14 at 8:00 a.m. PT -
Morgan Stanley Healthcare Conference - September 4-6, 2024
New York, New York -
Wells Fargo Healthcare Conference - September 4-6, 2024
Boston, Massachusetts
Fireside chat on Thursday, September 5 at 8:45 a.m. ET -
Jefferies London Healthcare Conference - November 19-21, 2024
London, England
Live and archived webcasts of select presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.
About GeneDx
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240812959337/en/
Investor Relations Contact:
investors@GeneDx.com
Media Contact:
press@GeneDx.com
Source: GeneDx
FAQ
What investor conferences will GeneDx (WGS) attend in 2024?
When is GeneDx's (WGS) panel discussion at the UBS Genomic Medicine Summit?
Where can I watch GeneDx's (WGS) investor conference presentations?
What is GeneDx's (WGS) stock exchange and ticker symbol?
What type of genetic tests does GeneDx (WGS) offer?
